68.9 F
New York
Thursday, June 30, 2022

One Of The Good Ones: Meta Materials Inc. (MMAT) Stock

Must read

Meta Materials Inc. (NASDAQ: MMAT), a producer of revolutionary materials, has secured the first US patent for its latest breakthrough technology for blood glucose monitoring.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Meta Materials’ UK subsidiary, Medical Wireless Sensing (MediWise), has secured a patent for their glucoWISE non-invasive glucose monitoring device. Without exaggeration, this is a breakthrough that allows you to detect the level of glucose in your blood without having to penetrate your skin.

Squeezing the glucoWISE gadget with your fingertips takes a measurement in 10 seconds and sends the data to a smartphone or other mobile device.

With the aid of a metamaterial from Meta Materials Inc. (MMAT), something previously thought impossible has been accomplished. This is a tiny nanocomposite with a complicated structure. The glucoWISE gadget emits high-frequency radio waves (40 GHz), which are directed into the skin by the nanocomposite, preventing wave reflections and incorrect readings.

It was impossible to create such a device without a metamaterial (an artificial substance having properties not present in nature). The metamaterial from Meta Materials Inc. (MMAT) was crucial in ensuring non-invasiveness. He made it possible to estimate the level of glucose with medically important precision using a small bit of capillary blood at the skin’s surface.

The glucoWISE device clearly has a large commercial potential. In the United States alone, 30 million individuals have diabetes, but many more need to get their blood sugar tested on a regular basis. Patients with diabetes, on the other hand, would prefer to take up to 10 measures every day if they didn’t have to pierce their skin.

As a result, glucoWISE stands to benefit from a strong start in sales. Most significantly, if Meta Materials Inc. (MMAT) is successful, it will demonstrate its inventive potential. Because Metamaterials has a wide range of applications, investors have responded favorably to the company’s message.

A closer examination of the stock price reveals that it is currently trading at +53.40 percent above its three-month low. The stock is now trading -92.74 percent below its 52-week high and 53.40 percent above its 52-week low.

More articles

Latest article



Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam